ELI LILLY & COMPANY signed an agreement with Prasco Laboratories to market the authorized generic version of Evista (raloxifene hydrochloride tablets), in 60 mg strength in the U.S. Prasco will begin shipping the product immediately. The financial terms of the agreement were not disclosed.
THE ATHENA BREAST HEALTH NETWORK adopted the Health Level Seven International-approved guide for sharing electronic data for breast cancer treatment. The guide was developed by the American Society for Clinical Oncology and approved through HL7 to become a national data standard.
DAVID COLE was named president of The Medical University of South Carolina and its affiliated medical centers.
THE US ONCOLOGY NETWORK and the Community Oncology Alliance sponsored a “Virtual Hill Day” to persuade members of Congress to stop the Centers for Medicare and Medicaid Services from applying the sequester cut to Medicare payments for cancer care drugs.
A study by a conservative think tank found large differences in performance of the FDA divisions, with oncology demonstrating the agency's fastest time from application submission to approval.
The overall economic return from the Women's Health Initiative estrogen plus progestin trial indicates that the changes in practice it produced provided a net economic return of $37.1 billion over 10 years.
The growth of global spending on oncology medicines has slowed over the past five years, according to a report by the IMS Institute for Healthcare Informatics.
National coverage for low-dose computed tomography may result in more harm than benefit to the Medicare population at this time, said Steven Woolf, a member of the Medicare Evidence Development & Coverage Advisory Committee.
When it appeared that CT screening for lung cancer was a shoo-in for Medicare coverage, the Lung Cancer Alliance, an advocacy group, started to certify “screening centers of excellence.”
Panel: Is It Really Up to LCA to Certify Centers?Moments before the hearing was closed to public comments, guest committee member Michael Gould asked Fenton-Ambrose to describe LCA's certification program for screening centers:
